Développement de protocoles antiémetiques en oncologie: Implication du pharmacien

Authors

  • Danielle Fagnan

DOI:

https://doi.org/10.4212/cjhp.v45i3.2626

Keywords:

algorithms, antiemetics, antineoplastic agents, protocols, algorithmes, antiémétiques, antinéoplasiques, protocoles

Abstract

ABSTRACT

The pharmacist implication in the development of antiemetic protocols in oncology is discussed. Following a review of literature, algorithms based on emetic potential of antineoplastic drugs have been presented to the oncology staff. Then, after the commercialization of ondansetron, new algorithms have been elaborated and are presented in this article. Considering the good results obtained, the pharmacists' suggestions concerning antiemetics are completely approved and followed by the oncology staff.

RÉSUMÉ

Cet article démontre l'implication du pharmacien dans le développement de protocoles antiémétiques en oncologie. Après une revue de la littérature, des algorithmes basés sur le potentiel émétogène des différents antinéoplasiques ont été présentés au personnel oeuvrant en oncologie. À la suite de la venue sur le marché d 'un nouveau médicament, l'ondansétron, les algorithmes ont été refaits et sont présentés dans cet article. Grâce aux bons résultats obtenus, les suggestions des phannaciens concernant les antiémétiques sont maintenant suivies à 100% par l'équipe medicale d'oncologie.

Downloads

Download data is not yet available.

Downloads

Published

2018-07-03

Issue

Vol. 45 No. 3 (1992)

Section

Articles

License

After publication of a manuscript in the CJHP, the authors of the manuscript must obtain written permission from the CSHP (publications@cshp.ca) before reproducing any text, figures, tables, or illustrations from the work in future works of their own. If a submitted manuscript is declined for publication in the CJHP, all said rights shall revert to the authors. Please note that any forms (e.g., preprinted orders and patient intake forms) used by a specific hospital or other health care facility and included as illustrative material with a manuscript are exempt from this copyright transfer. The CJHP will require a letter from the hospital or health care facility granting permission to publish the document(s). 

Copyright © Canadian Society of Hospital Pharmacists.